Letter from Immuno Ltd to Dr Eibl Dr Schwarz Dr Anderle and Mrs Diernhofer re product licence for feiba. Noted that CSM were unable on grounds of efficacy and quality to recommend the Licensing Authority to issue a product licence for feiba. Norman Berry noted that as CSM had not included on grounds of safety' they would not be prevented from continuing to sell on a doctor named patient basis.